NavaDerm and LSSCNY Announce Change in Clinical Leadership

* Leonard Bernstein, MD, becomes medical director of Laser & Skin Surgery Center of New York
* LSSCNY announces formation of Clinical Advisory Board
* Roy Geronemus, MD, will depart LSSCNY after 31 years

NEW YORK, Feb. 13, 2025 /PRNewswire/ -- NavaDerm Partners, LLC ("NavaDerm" or the "Company"), a dermatology platform and portfolio company of BelHealth Investment Partners, LLC ("BelHealth"), announced the appointment of Leonard Bernstein, MD, as medical director of Laser & Skin Surgery of New York ("LSSCNY").

Board-certified dermatologist and Mohs Surgeon, Leonard J. Bernstein, MD, is a graduate of Northwestern University College of Arts and Science where he received a Bachelor of Arts degree in Chemistry. He received his Medical Degree at Northwestern University School of Medicine. He completed a dermatology residency at Northwestern Memorial Hospital / Northwestern University, where he was a chief resident, followed by a Mohs Micrographic Surgery and Laser fellowship at the Laser and Skin Surgery Center of New York ®. Dr. Bernstein is an Assistant Clinical Professor of Dermatology at New York Hospital/ Cornell Medical Center and holds an appointment in the Department of Plastic Surgery/Dermatology at Mount Sinai Hospital / New York Eye and Ear Infirmary. He is a Fellow of the American Academy of Dermatology, American Society of Lasers in Medicine and Surgery, the American College of Mohs Micrographic Surgery and Cutaneous Oncology, and the Manhattan Metropolitan Dermatologic Society.  He is the author of many research journal articles as well as textbook chapters on various laser and surgical techniques.  He has lectured over the past 30 years at national dermatologic meetings and seminars.

LSSCNY also announced the formation of its Clinical Advisory Board, which includes board certified dermatologists and renowned experts in medical and cosmetic dermatology and will provide strategic clinical guidance to LSSCNY's medical director and NavaDerm's board. The Clinical Advisory Board will consist of Robert Anolik, MD, Yoon-Soo ("Cindy") Bae, MD, Roy Seidenberg, MD, and Ronald Shelton, MD. The Board will focus on maintaining LSSC's leadership and reputation for skin health care through innovative treatments and lasers. The Board will also rejuvenate LSSC's research capabilities and continue to work with leading device manufacturers and pharmaceutical companies.  

Cindy Bae, MD, a board-certified dermatologist and MOHS Surgeon, as well as a recipient of Castle Connolly Exceptional Women of the 2024 award, said, "I have had the pleasure of working closely with Dr. Bernstein for 11 years at LSSCNY and look forward to being part of the Clinical Advisory Board to further cement LSSCNY's leadership position in medical and cosmetic dermatology."

Inder Tallur, NavaDerm Chairman, stated "We are pleased with NavaDerm's positioning in the fast-growing dermatology sector made possible by our renowned physicians and Mohs surgeons who provide patients with excellent clinical care. We wish Dr. Geronemus the very best and thank him for his hard work at LSSCNY over the years. We truly have some of the country's top practicing dermatologists at LSSCNY and we will continue to provide them with the best support to provide quality care and service to their patients"

Dr. Bernstein stated "I am honored to become medical director of LSSCNY and continue to work alongside such esteemed and talented physicians. The newly created Board shows LSSCNY's and NavaDerm's commitment to remain at the forefront of innovation. I also look forward to bringing my experience as a physician to drive the best quality of care to our patients who come to us from all over the US and the world."

About Laser & Skin Surgery Center New York
LSSCNY is a world-renowned leader in cosmetic and general dermatology, dermatologic surgery, laser surgery and Mohs surgery. With 12 physicians and two locations in New York City and Southampton, LSSCNY is one of the largest and most preeminent dermatology groups in the United States. LSSCNY serves as a clinical research site with particular expertise in lasers and has had a long and successful history of executing clinical trials.

About NavaDerm
NavaDerm Partners, headquartered in New York City, is a Northeast-based dermatology management platform formed through the partnership of five dermatology groups in New York and New Jersey. Operating out of seven locations, NavaDerm's mission is to support its outstanding 50+ board-certified dermatologists and their dedicated staffs in providing outstanding patient care. NavaDerm's clinicians provide world-class and comprehensive general dermatology services across medical, surgical and cosmetic procedures.

About BelHealth Investment Partners
BelHealth Investment Partners, based in Fort Lauderdale, Florida, is a healthcare private equity firm focused on lower middle market companies. BelHealth has a unique combination of investing, executive management, and entrepreneurial experience. BelHealth acquires majority positions in entrepreneur-owned companies that it believes will benefit from its extensive operating and private equity investment expertise. BelHealth is investing from its current $350 million fund. For more information, visit www.belhealth.com.

For further information, please visit:
NavaDerm: www.navaderm.com
LSSCNY: www.laserskinsurgery.com
BelHealth Investment Partners: www.belhealth.com

Contact:
NavaDerm Partners: Vera Abramova (646) 644-7872
BelHealth Investment Partners: Inder Tallur (917) 975-6604

SOURCE BelHealth Investment Partners